PGHH:NSE:NSE-Procter & Gamble Hygiene and Health Care Limited (INR)

COMMON STOCK | Household & Personal Products |

Last Closing

USD 16221.4

Change

-10.75 (-0.07)%

Market Cap

USD 546.93B

Volume

6.13K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-06-21 )

Largest Industry Peers for Household & Personal Products

Symbol Name Price(Change) Market Cap
HINDUNILVR:NSE Hindustan Unilever Limited

-10.00 (-0.41%)

USD 5,736.18B
GODREJCP:NSE Godrej Consumer Products Limit..

-5.30 (-0.38%)

USD 1,387.81B
DABUR:NSE Dabur India Limited

-6.40 (-1.07%)

USD 1,051.60B
MARICO:NSE Marico Limited

-8.00 (-1.28%)

USD 788.48B
COLPAL:NSE Colgate Palmolive (India) Limi..

-1.60 (-0.06%)

USD 767.38B
EMAMILTD:NSE Emami Limited

-9.30 (-1.29%)

USD 306.45B
GILLETTE:NSE Gillette India Limited

+41.20 (+0.55%)

USD 245.59B
JYOTHYLAB:NSE Jyothy Labs Limited

-10.00 (-2.33%)

USD 163.50B
BAJAJCON:NSE Bajaj Consumer Care Limited

-2.06 (-0.77%)

USD 38.24B
CUPID:NSE Cupid Limited

-0.67 (-0.72%)

USD 25.12B

ETFs Containing PGHH:NSE

N/A

Market Performance

  Market Performance vs. Industry/Classification (Household & Personal Products) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -6.54% 44% F 23% F
Dividend Return 0.35% 13% F 32% F
Total Return -6.20% 44% F 23% F
Trailing 12 Months  
Capital Gain 14.01% 33% F 25% F
Dividend Return 1.16% 25% F 63% D
Total Return 15.17% 33% F 25% F
Trailing 5 Years  
Capital Gain 50.68% 57% F 21% F
Dividend Return 8.11% 45% F 64% D
Total Return 58.79% 57% F 22% F
Average Annual (5 Year Horizon)  
Capital Gain 12.20% 33% F 21% F
Dividend Return 13.76% 33% F 23% F
Total Return 1.56% 67% D+ 78% C+
Risk Return Profile  
Volatility (Standard Deviation) 16.46% 87% B+ 93% A
Risk Adjusted Return 83.60% 93% A 74% C
Market Capitalization 546.93B 67% D+ 91% A-

Annual Financials (INR)

Quarterly Financials (INR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.